Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma

Archives of Iranian Medicine

Volumn 13, Issue 6, 2010, Pages 498-503

  Ahmadi, Seyed Ali ^a   Moinfar, Mahnaz ^a   Moghaddam, Katayoun Gohari ^b   Bahadori, Moslem ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiogenesis modulating agents; Angiogenic proteins; Prostatic neoplasms

Indexed keywords

CD34 ANTIGEN; LAMININ;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; GLEASON SCORE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MICROVASCULATURE; MICROVESSEL DENSITY; PERINEURIUM; PERIODIC ACID SCHIFF STAIN; PROSTATE ADENOCARCINOMA; PROSTATE SMOOTH MUSCLE CELL; SMOOTH MUSCLE FIBER; TUMOR VASCULARIZATION; TUMOR VOLUME; VASCULAR ENDOTHELIUM; VASCULAR MIMICRY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; ANTIGENS, CD34; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS;

EID: 78649437703     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Brawer M. Quantitative microvessel density: a staging and prognostic marker for human prostatic carcinoma. Cancer. 1996; 78: 345-349.
2. de la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, et al. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol. 2000; 113: 555-562.
3. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS. 2004; 112: 508-525.
4. Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer. 1997; 79: 772-779.
5. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Péer J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999; 155: 739-752.
6. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000; 156: 361-381.
7. Sharma N, Seftor REB, Seftor EA, Gruman LM, Heidger Jr PM, Cohen MB, et al. Tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. The Prostate. 2002; 50: 189-201.
8. Liu C, Huang H, Donate F, Dickinson C, Santucci R, El Sheikh A, et al. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res. 2002; 62: 5470-5475.
9. Buijs JT, Cleton AM, Smit VTHBM, Löwik CWGM, Papapoulos SE, Pluijm GVD. Prognostic significance of periodic acid-schiff-positive patterns in primary breast cancer and its lymph node metastases. Breast Cancer Res Treat. 2004; 84: 117-130.
10. Sood AK, Seftor EA, Fletcher MS, Gardner LMG, Heidger PM, Buller RE, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol. 2001; 158: 1279-1288.
11. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem. 2005; 53: 997-1002.
12. Sun B, Zhang S, Zhao X, Zhang W, Hao X. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol. 2004; 25: 1609-1614.
13. Cai XS, Jia YW, Mei J, Tang RY. Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. Chin Med J (Engl). 2004; 117: 94-98.
14. Guzman G, Cotler SJ, Lin AY, Maniotis AJ, Folberg R. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med. 2007; 131: 1776-1781.
15. Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res. 2006; 312: 594-607.
16. Los M, Roodhart JM, Voest EE. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. The Oncologist. 2007; 12: 443-450.
17. Hendrix MJC, Seftor EA, Hess AR, Seftor REB. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003; 3: 411-421.
18. Sanz L, Feijoo M, Blanco B, Serrano A, Alvarez- Vallina L. Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells. Cancer Immunol Immunother. 2003; 52: 643-647.
19. Epstein JI, Allsbrook Jr WC, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005; 29: 1228-1242.
20. Folberg R, Rummelt V, Paryz-Van Ginderdeuren R, Hwang T, Woolson RF, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993; 100: 1389-1398.